Prior to the COVID-19 pandemic, clinical laboratories were facing increased patient volumes, a rise in chronic illnesses, and an increasingly educated patient population demanding real-time information. Now, as labs transition to new ways of thinking and working, many are looking for strategies to properly manage the rising costs that result from these factors. Utilization management is key to maintaining revenue and reducing costs, and can be leveraged to gain institutional buy-in and visibility. This webinar uses case studies to illustrate these strategies, while breaking down the myth of the "high fixed-cost lab" as a barrier to action.
Mike Broyles, BS Pharm, PharmD addresses procalcitonin aided antibiotic stewardship, and reviewing current biomarkers used in the management of bacterial infection.